Arti Rai and Colleen Chien are studying whether the Supreme Court's decisions in Mayo v Prometheus and Bilski v Kappos have had a negative impact on diagnostics innovation.
Beef producers in Australia are fighting a bovine genome patent awarded to US companies, the ABC reports.
The USPTO has become involved in the CRISPR-Cas9 patent dispute.
A court of appeals will not reconsider the validity of Sequenom's '540 patent, saying it is bound by previous cases regarding patenting laws of nature.
The report, which takes a look at patent issues as it relates to confirmatory genetic tests, acknowledged that federal legislation has dramatically changed the landscape in recent years.
The Australian High Court rules that isolated genetic material cannot be patented.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
A decision is expected soon in Australia's gene patenting court case.
Patent law experts said the ruling provides further clarity over what is and is not patentable within the broader molecular diagnostics field.
The decision invalidates 13 claims of a patent that is at the center of litigation filed by Illumina alleging infringement by Ariosa Diagnostics.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.